Publicação:
Therapeutic interventions to reduce the risk of progression from prediabetes to type 2 diabetes mellitus

dc.contributor.authorMclellan, Katia Cristina Portero [UNESP]
dc.contributor.authorWyne, Kathleen
dc.contributor.authorVillagomez, Evangelina Trejo
dc.contributor.authorHsueh, Willa A.
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionWeill Cornell Med Coll
dc.date.accessioned2014-12-03T13:10:37Z
dc.date.available2014-12-03T13:10:37Z
dc.date.issued2014-01-01
dc.description.abstractClinical trials have demonstrated that it is possible to prevent diabetes through lifestyle modification, pharmacological intervention, and surgery. This review aims to summarize the effectiveness of these various therapeutic interventions in reducing the risk of progression of prediabetes to diabetes, and address the challenges to implement a diabetes prevention program at a community level. Strategies focusing on intensive lifestyle changes are not only efficient but cost-effective and/or cost-saving. Indeed, lifestyle intervention in people at high risk for type 2 diabetes mellitus (T2DM) has been successful in achieving sustained behavioral changes and a reduction in diabetes incidence even after the counseling is stopped. Although prediabetes is associated with health and economic burdens, it has not been adequately addressed by interventions or regulatory agencies in terms of prevention or disease management. Lifestyle intervention strategies to prevent T2DM should be distinct for different populations around the globe and should emphasize sex, age, ethnicity, and cultural and geographical considerations to be feasible and to promote better compliance. The translation of diabetes prevention research at a population level, especially finding the most effective methods of preventing T2DM in various societies and cultural settings remains challenging, but must be accomplished to stop this worldwide epidemic.en
dc.description.affiliationSao Paulo State Univ, Dept Publ Hlth, Sch Med, Botucatu, SP, Brazil
dc.description.affiliationWeill Cornell Med Coll, Div Diabet Obes & Lipids, Dept Med, Methodist Hosp Diabet & Metab Inst, Houston, TX USA
dc.description.affiliationWeill Cornell Med Coll, Houston Methodist Res Inst, Houston, TX USA
dc.description.affiliationUnespSao Paulo State Univ, Dept Publ Hlth, Sch Med, Botucatu, SP, Brazil
dc.description.sponsorshipConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.format.extent173-188
dc.identifierhttp://dx.doi.org/10.2147/TCRM.S39564
dc.identifier.citationTherapeutics And Clinical Risk Management. Albany: Dove Medical Press Ltd, v. 10, p. 173-188, 2014.
dc.identifier.doi10.2147/TCRM.S39564
dc.identifier.fileWOS000333182300001.pdf
dc.identifier.issn1176-6336
dc.identifier.urihttp://hdl.handle.net/11449/112317
dc.identifier.wosWOS:000333182300001
dc.language.isoeng
dc.publisherDove Medical Press Ltd
dc.relation.ispartofTherapeutics And Clinical Risk Management
dc.relation.ispartofsjr0,748
dc.rights.accessRightsAcesso aberto
dc.sourceWeb of Science
dc.subjectlifestyleen
dc.subjectT2DMen
dc.subjectinterventionen
dc.subjectpreventionen
dc.titleTherapeutic interventions to reduce the risk of progression from prediabetes to type 2 diabetes mellitusen
dc.typeArtigo
dcterms.rightsHolderDove Medical Press Ltd
dspace.entity.typePublication
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatupt
unesp.departmentSaúde Pública - FMBpt

Arquivos

Pacote Original

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
WOS000333182300001.pdf
Tamanho:
295.05 KB
Formato:
Adobe Portable Document Format